Your browser doesn't support javascript.
loading
[Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future].
Gamidov, S I; Ovchinnikov, R I; Popova, A Yu; Izhbaev, S Kh.
Afiliação
  • Gamidov SI; Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
  • Ovchinnikov RI; Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
  • Popova AY; Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
  • Izhbaev SK; Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
Urologiia ; (1): 103-107, 2017 Apr.
Article em Ru | MEDLINE | ID: mdl-28394532
ABSTRACT
This review article describes the differences in efficacy and side effects between available phosphodiesterase type 5 (PDE-5) inhibitors used for treating erectile dysfunction. The most studied PDE-5 inhibitor is sildenafil.
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Fosfodiesterase 5 / Disfunção Erétil Limite: Humans / Male Idioma: Ru Revista: Urologiia Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Fosfodiesterase 5 / Disfunção Erétil Limite: Humans / Male Idioma: Ru Revista: Urologiia Ano de publicação: 2017 Tipo de documento: Article